June 20, 2011
Life value
STELLAPHARM was born to care and protect patient’s health, to help enhancing their lives and living longer. Your health, for today and for future.
STADA-VN has been acknowledged as one of the most prestigious enterprises on the domestic pharmaceutical market. Recently, STADA-VN has held a “Customer Conference” in Binh Duong province on 18 June 2011 in order to show the deep gratitude to closed partners and customers for their supports during the last time.

Over 200 doctors and pharmacists from hospitals, clinics, pharmacy stores and many agencies in Binh Duong province have attended the conference.
STELLAPHARM is one of leading generics pharmaceutical companies and strong producer of anti-viral drugs in Vietnam. The company established in Vietnam in 2000; and focuses on both prescription drugs and non-prescription especially in cardiovascular diseases, anti-viral drugs, anti-diabetics drugs, etc. and our products are now used by millions of patients in more than 50 countries worldwide.
The company is globally recognized for its quality through our facilities have been audited and approved by stringent authority like EMA, PMDA, Taiwan GMP, local WHO and others.
Additional information for this article: Stellapharm J.V. Co., Ltd. – Branch 1
A: 40 Tu Do Avenue, Vietnam – Singapore Industrial Park, An Phu Ward, Thuan An Town, Binh Duong Province, Vietnam
T: +84 274 376 7470 | F: +84 274 376 7469 | E: info@stellapharm.com | W: www.stellapharm.com
Stellapharm J.V. Co., Ltd. – Branch 1 has just been certified by Bureau Veritas Certification – an international certification organization in the field of inspection, testing and certification – compliance with two international standards ISO 14001: 2015 and ISO 45001: 2018 for all pharmaceutical production, distribution and export activities. As a business operating in health
On July 18, 2025, STELLAPHARM J.V. Co., Ltd. – Branch 1 achieved the EU – GMP (Good Manufacturing Practice) certification issued by the competent authority, the Croatian Agency for Medicinal Products and Medical Devices (HALMED) and the information is published on the EudraGMDP database of the European Union. Achieving this certification not only enhances the